Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Regulation of HLA class II expression in mutants of blymphoblastoid cell lines

Thesis/Dissertation ·
OSTI ID:6601251
In an effort to identify factors involved in the regulation of the expression of human major histocompatibility complex class II antigens, a series of mutants were derived that failed to express certain of these molecules on their plasma membranes. This was accomplished by exposing the cells to {gamma}-irradiation and selecting for the loss of expression of class II antigens using antibody and complement. One such mutant designated HMy2.DRN no longer expressed HLA-DR molecules on its cell surface. Cell surface expression was found to be restored by transfecting a wildtype DRA but not a DRB cDNA suggesting a structural mutation in the DRA mRNA or protein was responsible for the lack of cell surface expression. Nucleotide sequence analysis of the DRA mRNA from HMy2.DRN revealed a 75 nucleotide deletion corresponding to the start of the {alpha}2 domain and involving one of two cysteines that are involved in the formation of an intrachain disulfide bond. At the biochemical level, only minute quantities of HLA-DR could be precipitated from this cell line following a 4 hour continuous label with {sup 35}S-methionine. HLA-DR{beta} and the class II associated invariant chain could be seen coprecipitating with the mutant DR suggesting a process of normal assembly. However by carrying out the labeling at 16{degree}C instead of 37{degree}C, equivalent amounts of HLA-DR could be precipitated from parent and mutant alike.
Research Organization:
Duke Univ., Durham, NC (USA)
OSTI ID:
6601251
Country of Publication:
United States
Language:
English